Br J OphthalmolJuly 202211 citations
Patient-reported outcome measures should not be the primary outcome in glaucoma clinical trials of disease modification.
Rabiolo Alessandro, Barton Keith, McNaught Andrew Ian
Abstract
No abstract available.
MeSH Terms
HumansGlaucomaPatient Reported Outcome MeasuresClinical Trials as Topic
Shields Classification
Related Articles5
Age-period-cohort analysis of the global burden of visual impairment according to major causes: an analysis of the Global Burden of Disease Study 2019.
Cohort StudyBr J Ophthalmol20249 citationsSame chapter
Clinical Outcomes of Therapeutic Interventions for Autoimmune Retinopathy: A Meta-analysis and Systematic Review.
Meta-AnalysisOphthalmol Sci20245 citationsSame chapter
The Impact of Race, Ethnicity, and Sex on Fairness in Artificial Intelligence for Glaucoma Prediction Models.
Observational StudyOphthalmol Sci202413 citationsSame chapter
Absolute Risks and Decision Tools for Communicating the Risks of Visual Impairment From Myopia-Related Diseases.
ReviewInvest Ophthalmol Vis Sci20253 citationsSame chapter
Racial Disparities in Glaucoma Vision Outcomes and Eye Care Utilization: An IRIS Registry Analysis.
Cohort StudyAm J Ophthalmol202415 citationsSame chapter
Is this article assigned to the wrong chapter(s)? Let us know.